NCT05877326

Brief Summary

Postoperative delirium (POD) is a critical complication of major surgery and affects up to 70% of surgical patients over the age of 60 years. The additional healthcare costs associated with delirium exceed €50,000 per patient per year due to prolonged hospital stay, increased risk of long-term care or institutionalization, and the risk of developing dementia or cognitive impairment . Therefore, prevention of POD is a major goal in the perioperative setting. The investigator proposes this randomized study to evaluate the interest of a reduced anesthetic depth to prevent short-term cognitive disorders after cardiac surgery in elderly subjects. Method: Patients over 75 years old scheduled to undergo one of the cardiac surgeries of interest (valvular, coronary bypass, aortic or combined surgery) will be randomized to 2 paralell arms :

  • Perioperative anesthesia with a BIS (Bispectral index) target of 35
  • Perioperative anesthesia with a BIS(Bispectral index) target of 55 The presence of mental confusion will be determined by CAM-ICU ( Confusion Assessment Method for the ICU ) at day 3 post procedure. Ancillary study: To assess cognitive status at inclusion, discharge and third post operative month using the MOCA(Montreal Cognitive Assessment ). Conclusion:The hypothesis of this study is that a lower depth of anesthesia will reduce post operative delirium in the first three days in patients older than 75 years who are planned for valvular, coronary artery bypass, aortic or combined cardiac surgery .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 26, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2025

Completed
Last Updated

June 13, 2023

Status Verified

June 1, 2023

Enrollment Period

1.7 years

First QC Date

May 2, 2023

Last Update Submit

June 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • To demonstrate the benefit of reduced depth of anesthesia

    The presence of mental confusion using CAM-ICU ( The Confusion Assessment Method for the Intensive Care Unit )

    Day 3 post intervention.

Study Arms (2)

Perioperative anesthesia with a BIS target of 35

ACTIVE COMPARATOR

Anesthesia with a BIS target of 35

Drug: General anesthesia with propofol or sevofluraneBehavioral: CAM-ICU (Confusion Assesment Method ICU) at day 3 post-operative

Perioperative anesthesia with a BIS target of 55

ACTIVE COMPARATOR

Anesthesia with a BIS target of 55

Drug: General anesthesia with propofol or sevofluraneBehavioral: CAM-ICU (Confusion Assesment Method ICU) at day 3 post-operative

Interventions

General anesthesia

Also known as: General anesthesia with 35 BIS target or 55 BIS target
Perioperative anesthesia with a BIS target of 35Perioperative anesthesia with a BIS target of 55

The presence of mental confusion will be determined by CAM-ICU at J3 post intervention.

Perioperative anesthesia with a BIS target of 35Perioperative anesthesia with a BIS target of 55

Eligibility Criteria

Age75 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patient aged between 75 and 85 years, who signed an informed consent, undergoing elective valvular, coronary artery bypass, aortic or combined cardiac surgery
  • Be affiliated to French Health Insurance

You may not qualify if:

  • Refusal of consent -Patient unable to read, write or understand French
  • Vulnerable patient according to article L1121-6 of the CSP,
  • Patient of legal age under guardianship or curatorship or under legal protection,
  • Patient unable to give personal consent according to article L.1121-8 of the CSP or adult protected by law,
  • Patient having already participated in the present study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre cardiologique du nord

Saint-Denis, 93200, France

Location

Related Publications (1)

  • Ellouze O, Zogheib E, Abdelhafidh K, Lemaire A, Berger J, Charfeddine A, Bouzguenda H, Konstantinou M, Molinari N, Bonnet N, Geri G, Nappi F. Anaesthetic depth and short-term delirium after cardiac surgery intervention: the study protocol of the BISCAR multicentre randomised clinical trial. BMJ Open. 2025 Aug 28;15(8):e103105. doi: 10.1136/bmjopen-2025-103105.

MeSH Terms

Conditions

Emergence Delirium

Interventions

Anesthesia, GeneralPropofolSevoflurane

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and AnalgesiaPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsMethyl EthersEthersHydrocarbons, FluorinatedHydrocarbons, Halogenated

Study Officials

  • Ellouze Omar, MD

    Centre Cardiologique du Nord

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ellouze Omar, MD

CONTACT

Moussouni karima, CRA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Multicenter, controlled, randomized, two parallel-arm trial: Perioperative anesthesia with a BIS target of 35 Perioperative anesthesia with a 55% BIS target
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2023

First Posted

May 26, 2023

Study Start

September 1, 2023

Primary Completion

May 10, 2025

Study Completion

May 10, 2025

Last Updated

June 13, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

The sponsor and the persons acting on its behalf will have access to the data. In addition, only the persons delegated by the investigating physician, health or research professionals, involved in the realization of the research and subject to professional secrecy, will have access to these coded data.

Locations